CS Paper Radar

NanoNet: Ultra-Lightweight Network for MRI Brain Tumor Classification toward Edge AI

Tran Nguyen-Le, Huu-Thuan Huynh, Minh-Triet Tran, Trung-Nghia Le

cs.CV ·submitted 2026-11-08 02:01 UTC · v1
benchmark

Abstract

Automated brain tumor classification from magnetic resonance imaging (MRI) can support accessible medical image analysis, but conventional deep learning models often exceed the resource budgets of highly constrained edge-AI platforms. We present NanoNet, an ultra-lightweight convolutional neural network designed for resourceconstrained MRI classification and motivated by future edge-AI applications. Inspired by MobileNetV2, NanoNet substantially reduces network depth, channel capacity, expansion ratios, and final feature dimensionality, resulting in only five inverted residual blocks and 8,132 parameters. We further investigate dependency-aware structured pruning, knowledge distillation, and INT8 quantization-aware training for additional compression. Experiments on the BRISC 2025 benchmark show that NanoNet achieves 92.80% accuracy and 92.97% macro F1 with 8,132 parameters and 10.498 MFLOPs. Across three compression seeds, it exceeds the mean accuracy of 70%-pruned MobileNetV2 by 5.20 percentage points while using 60.2% fewer parameters and 9.8% less computation. Converted INT8 NanoNet achieves 89.70% accuracy and 90.22% macro F1 across three QAT seeds. Earlier TensorFlow Lite measurements indicate 27.7 KB of baseline model storage, motivating future edge-AI deployment.

Closest papers

Nearest neighbours by meaning across the whole index.

BrainAid: Efficient Brain Tumor Detection Using Lightweight CNNs and Explainable AI for Resource-Constrained Environments

cs.CV ·2026-10-10 ·Sai Sriram Gonthina, Ross Gore, Bikash Chandra Singh, Pronaya Bhattacharya, Sachin Shetty +2 more
similarity 0.71
Abstract

A brain tumor is an unusual growth of cells in the brain that can be cancerous or not, affecting normal brain function and causing serious risk to health. Existing solutions for brain tumor classification, such as expert manual evaluations of magnetic resonance imaging (MRI) scans, are generally inconsistent as different professionals have different criteria and can be resource-intensive, leading to delayed diagnoses. Additionally, while deep learning models have demonstrated potential, they typically require significant computational resources, motivating the need for more efficient and accessible diagnostic tools that can be deployed in real-time healthcare settings. To address these limitations, this study presents BrainAid, which makes efficient use of Convolutional Neural Networks (CNNs) and Vision Transformers (ViTs) for effective classification of four-class classification of glioma, meningioma, pituitary tumor, and no-tumor MRI scans, outperforming all the standard models such as VGG16, Inception-V3, ResNet-50 and so, while integrating Explainable AI (XAI) to improve interpretability. The BrainAid is trained to classify tumors with a high precision of 98%, achieving an F1 score of 98% and an accuracy of 98% using publicly available dataset. The model is deployed on a Raspberry Pi, demonstrating efficiency in low-resource environments. This system shows the feasibility of real-time, edge-based tumor classification, providing quick diagnostic support for medical professionals and enhancing patient care in resource-limited healthcare facilities and underserved areas.

0.07

Robust Lightweight Deep Learning Models for Oral Cancer Screening

cs.AI ·2026-08-21 ·Siddhant Bharadwaj, Aakash Shedsale, Tejashree Subramanya, Mohd. Azfar, Praveen Birur +4 more
published similarity 0.71
Abstract · 10 pages, 3 figures, Paper accepted for the 6th International Conference on AI-ML Systems, 2026

Oral cancer is a leading cause of mortality in low-to-middle-income countries, where a shortage of specialists delays diagnosis. While point-of-care screening via smartphones offers a scalable solution, developing robust AI for resource-constrained settings poses significant challenges, including class imbalance in training data, variable data quality, and computational constraints on edge devices. In this paper, we present the optimisation of lightweight deep learning models for smartphone-based oral cancer screening. Using a diverse, multi-centre retrospective dataset of approximately 30,000 images acquired over a decade, we systematically evaluate state-of-the-art convolutional, transformer, and hybrid architectures. Through rigorous pipeline ablation, we demonstrate that directly optimising hybrid architectures for the edge strictly outperforms computationally heavy paradigms, such as large models or knowledge distillation. Furthermore, interpretability analysis and simulated noise-stress tests revealed that the system anchors on clinical features and remains robust to unstructured sensor noise, despite vulnerabilities to impulse bit errors. In the held-out test set, our optimised MobileViTv2 models achieved an average sensitivity of 83.2 $\pm$ 1.5% and an average specificity of 86.0 $\pm$ 0.8%, with the best model exhibiting 87.4% sensitivity, 86.5% specificity, and a critical negative predictive value of 97.2% with reference to specialist labels. These results confirm that with targeted architectural selection and streamlined optimisation, interpretable and robust lightweight AI models exhibit high potential for edge deployment to enable automated triage in primary care settings.

0.30

Quality-Governed Deep Learning Network for Brain Tumor MRI Segmentation

cs.CV cs.AI ·2026-11-03 ·Asifiqbal Saiyed, Nitesh Chilakala, Jimmy Joseph, Praneetha Goli, Rohini Maskar
published similarity 0.70
Abstract

The segmentation of brain tumors from magnetic resonance imaging (MRI) is an essential step for computer-aided neuro-oncology, treatment planning and follow-up. While effective encoder-decoder representations are achieved by U-Net and Attention U-Net, the skip sections of the network can generate weak-contrast or noisy responses in the case of heterogeneous boundaries of the tumor. In this paper, we introduce a Quality-Governed Deep Learning Network (QGDL-Net) that can be used for binary tumor segmentation from FLAIR MRI slices. The proposed model is able to predict the slice quality based on contrast and SNR statistics and to fine-tune the encoder features prior to decoding by learnable quality gates. We used the 80:20 train-validation split for experiments with BraTS 2021. QGDL-Net achieved a Dice of 0.9747, IoU of 0.9506, precision of 0.9755, recall of 0.9739, F1 of 0.9747 and accuracy of 0.9982, outperforming U-Net and Attention U-Net. The EigenCAM maps and segmentation overlays provide better tumor localization and interpretable activation around the lesion regions.

0.30

Benchmarking CNNs, Vision Transformers, and Foundation Models for Explainable Brain Tumor MRI Classification: Calibration, Decision Analysis, and External Validation

cs.CV ·2026-11-09 ·Akwasi Asare
similarity 0.69
Abstract · Under review at Scientific Report Journal, Springer

Deep learning models for brain tumor MRI classification are usually compared by accuracy alone, on public datasets whose independence is rarely checked. We benchmarked six architectures: two convolutional networks (EfficientNetV2-M and ConvNeXt-V2-Tiny), two vision transformers (Swin-V2-S and ViT-L/16), and two foundation models (DINOv2-L and MedSigLIP-448), for four-class classification of 7,216 public MRI images. We assessed accuracy, calibration, explainability, ensembles, and decision curves, with every fitted quantity estimated on validation data only. Pixel-verified duplicate screening showed that 36% of the test images had a near-duplicate in the training data. Test accuracy ranged from 94.5% to 95.6%, with no pairwise difference after Holm correction, and fell to 90.3% to 91.7% on the 773 test images free of duplicates and shared patients. Ensembles did not outperform the best single model. Attribution maps passed a model-randomization test but localized expert-annotated tumors poorly. On 1,675 external BDNeuro-MRI images that did not duplicate the training data, accuracy ranged from 77.6% (MedSigLIP-448) to 95.0% (ViT-L/16), and 12 of 15 pairwise differences were significant. Internal accuracy on this public collection therefore did not distinguish the architectures, whereas the duplicate-filtered external test did.

0.15

Interpretable Deep Learning Models for Breast Cancer Diagnosis Using Medical Imaging

cs.CV cs.AI ·2026-10-27 ·Sami Alnawali, Muhammad Atif Saeed, Abdul Hadi, Azka Atiq, Akhtar Jamil +1 more
benchmark similarity 0.68
Abstract · 37 page, 45 Figures

Deep learning shows promise for breast cancer diagnosis, but limited interpretability hinders clinical adoption. We benchmark ten ImageNet-pretrained models (ResNet50, VGG19, InceptionV3, DenseNet121, Xception, MobileNetV2, EfficientNet, ConvNeXt, ViT, and Swin Transformer) for benign-versus-malignant classification on the BreakHis histopathology dataset using a patient-level split, and explain their predictions with Grad-CAM, LIME, Integrated Gradients, and LRP. DenseNet121 performed best, with 99.4% test accuracy and an AUC-ROC of 0.999, and significantly outperformed all other models (p < 0.001). Transformer-based models trailed the CNNs. The explanations consistently highlighted nuclei-rich and glandular regions of diagnostic relevance. Combining transfer learning with explainable AI can thus yield accurate, interpretable tools for breast cancer diagnosis.

0.19

Explainable and CPU-Efficient Brain Tumor Classification from MRI Using Two-Phase EfficientNetB3 Fine-Tuning

cs.CV ·2026-11-18 ·Deepro Das, Saad Kabir Uddin, Mohammad Alauddin, Bornali Sarker, Thasnim Akhter
similarity 0.67
Abstract · 6 pages, 5 figures, 6 tables

Brain tumors are among the most lethal neurological disorders, with over 308,000 new diagnoses annually worldwide. Accurate classification of tumor type from Magnetic Resonance Imaging (MRI) scans is critical for treatment planning; however, manual radiological interpretation is time-consuming and prone to inter-observer variability. This paper proposes an automated deep learning pipeline for four-class brain MRI classification (glioma, meningioma, no tumor, and pituitary tumor) using EfficientNetB3 transfer learning with a custom classification head. A two-phase training strategy is adopted: Phase 1 trains the head with a frozen backbone (best validation accuracy: 92.77%), and Phase 2 selectively fine-tunes the top 37 layers at a 100x reduced learning rate (best validation accuracy: 94.91%). On an independent balanced test set of 1,600 MRI images, the system achieves 90.62% overall accuracy and a macro-average AUC of 0.9854. Gradient-weighted Class Activation Mapping (Grad-CAM) is integrated for class-discriminative visual explainability. The proposed system simultaneously addresses three dimensions absent in prior work: high accuracy, CPU-only computational efficiency, and clinical interpretability.

0.14

IFC-SSL-Bench: Benchmarking Self-Supervised Learning for Annotation-Efficient Multispectral Imaging Flow Cytometry

cs.CV ·2026-10-22 ·Angelo Jovin Yamachui Sitcheu, Roxana-Teodora Fetescu, Thomas Lautenschlager, Nils Friederich, Linus Schilpp +4 more
benchmark similarity 0.67
Abstract · 35 pages, six main figures, seven supplementary figures, five tables and four supplemntary tables

Imaging Flow Cytometry (IFC) generates large multispectral datasets, yet the need for expert annotations bottlenecks the development of supervised deep learning models. While Self-Supervised Learning (SSL) offers a solution, its application to IFC remains fragmented and lacks systematic benchmarking. To address this, we present IFC-SSL-Bench, a modular framework for evaluating SSL in IFC. We benchmark six SSL approaches across four backbones on two heterogeneous datasets. By assessing downstream classification performance across annotation regimes of the training sets (1%-100%), we quantify annotation efficiency and identify optimal configurations for high-dimensional biological imaging. SSL matches the performance of fully supervised baselines trained on 100% of annotated data while using as little as 5% of annotations for morphological classification, with advantages in low-data regimes below 5%. Across both datasets, the contrastive approach MoCo-v2 paired with ConvNeXt backbones emerged as the top-performing configuration, with ConvNeXtV1-T best for immunological synapse classification and ConvNeXtV2-T for morphological classification. We identify a clear pattern in transfer dynamics: ImageNet initialization benefits morphological classification, consistent with its visual similarity to natural images, whereas random initialization better captures the more domain-specific immunological synapse classification. SSL elevates class-specific F1-scores by over 35 percentage points for structurally complex classes at 1% of annotated data. We synthesize these insights into a unified set of guidelines for deploying self-supervised workflows in high-throughput IFC, and release the benchmark as a resource for future work.

0.27

How Robust Are CNNs and Vision Transformers for Alzheimer's MRI Classification Across Datasets?

cs.CV ·2026-10-24 ·Hafija Aktar, Molly Croes, Frank S. Menniti, Abdeltawab Hendawi
dataset similarity 0.67
Abstract · 12 pages, 9 tables, 3 figures. Submitted to Biomedical Signal Processing and Control

Accurate assessment of Alzheimer's disease stages from MRI is important for understanding disease progression and supporting the development of computer-aided analysis tools. Deep learning models have shown promising results for Alzheimer's disease classification from MRI. However, when evaluated on single datasets, it is difficult to determine whether the observed performance reflects consistent architectural behavior or dataset-specific effects. In this work, we present a multi-dataset benchmarking framework with standardized preprocessing and evaluation. We compare five architectures: ResNet-50, ReXNet-150, Swin Transformer, ViT-Base, and ViT-Large. The models are evaluated across three MRI datasets representing severe class imbalance, train-test distribution mismatch, and large-scale augmentation. The results show broadly consistent performance patterns across datasets, with ViT-Large achieving the best performance on all three datasets and reaching up to 99.84% accuracy and 99.86% macro F1. Performance differences between architectures are most pronounced under distribution mismatch and considerably smaller in the augmented-data setting. Across datasets, lower class-level performance is observed primarily among adjacent early-stage categories, particularly Very Mild and Mild impairment. These findings highlight the importance of evaluating deep learning architectures across multiple data conditions rather than relying on single-dataset performance.

0.20